Delivery Order SPE2DB24D2012-SPE2DB24FBUQM
Award Date
4/8/24
Potential Completion Date
4/9/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,721.40 firm fixed-price delivery order is for the supply of 4567174831 VYVANSE 40 MG CAPSULE 100S. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with ID SPE2DB22D3019|SPE2DB24FK3EP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The contract is for the delivery of 4564260054 - VYVANSE 40 MG CAPSULE 100S, a brand name pharmaceutical product. This is a firm-fixed-price delivery order with a ceiling value of $5,297.16 and a performance period through April 10, 2024. No...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,874.71 firm fixed-price delivery order contract is for the supply of 4567375621 - VYVANSE 40 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The $2,849.12 contract is for the supply of VYVANSE 30 MG CAPSULE 100S to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, valued at up to $999,999,999.00 through December 2025....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYVANSE 20 MG CAPSULE 100S. The total ceiling value of the contract is $1,535.33 and the ultimate completion date is April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00 and a...
This federal contract award, identified as SPE2DB20D1047|SPE2DB24FF90Y, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $6,235.17 firm fixed price delivery order is for the supply of 4,565,978,406 units of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract does not have a set-aside designation and has an ultimate completion date of September 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, has...
This federal contract award, with ID SPE2DX15D1021|SPE2DX24FHRFQ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,988.52 firm fixed price delivery order is for the supply of 4564158404 VYVANSE 40 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp holds...
The U.S. Defense Logistics Agency (DLA) awarded a $1,664.92 firm fixed price delivery order to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 4565803456 VYVANSE 40 MG CAPSULE 100S, a medication, with a period of performance through September 16, 2024. This award was not set aside for any particular business type. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,120.14 firm-fixed-price delivery order is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $6,166.40, is for the delivery of 20 mg capsules of the drug VYVANSE. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA,...